Cancer News and Research

Latest Cancer News and Research

Arthritis pain relief drug ALEVE now available OTC in British Columbia

This winter, British Columbians may be inspired to increase their activity level and take part in some favourite winter pastimes. For those who have joint and arthritis pain, getting back to doing the activities they love may be more of a challenge. ALEVE(R) is the first over-the-counter naproxen sodium tablet, and is now available province-wide. With just one pill, ALEVE(R) offers convenient access to pain relief for up to 12 hours.

29 Jan 2010

APF survey reveals breakthrough cancer pain causes medical and financial hardships for cancer patients

A new survey released today by the American Pain Foundation (APF) reveals that breakthrough cancer pain — sudden, temporary flares of severe pain that occur even when pain medication is used — is one of the most challenging aspects of having cancer, according to three out of four (75 percent) U.S. adults who have ever been diagnosed with cancer and experience this type of pain.

29 Jan 2010

OMT, a viable option for treating back pain in the third trimester of pregnancy

For many pregnant women, it's inevitable. As their pregnancy progresses, tasks that involve the low back often get more difficult. It is harder to bend over, lift, sit or walk for long periods of time, and back pain increases. Treating back pain, and improving daily function relative to tasks that involve the low back is a challenge because pregnant women are limited to treatments that will not create problems for their developing baby.

29 Jan 2010

Genzyme implements new annual and long-term incentive plans for senior executives

Genzyme Corporation announced today that it has adopted new annual and long-term incentive plans for senior executives that will be utilized beginning in 2010.

29 Jan 2010

iPierian receives UK patent for induced pluripotent stem cell technology

iPierian, Inc., a biopharmaceutical company focused on changing the paradigm of drug discovery and development through the application of cellular reprogramming, today announced that the Intellectual Property Office in the United Kingdom has issued a Notification of Grant to iPierian for UK patent No. GB2450603, its first patent related to induced pluripotent stem cell (iPSC) technology.

29 Jan 2010

People with early-stage lung cancer may double their chances of surviving by giving up smoking

People with early-stage lung cancer may double their chances of surviving for longer than five years by giving up smoking, UK scientists have found.

28 Jan 2010

ChemoCentryx announces the initiation of Phase I clinical trial of CCX168

ChemoCentryx, Inc., today announced the initiation of a Phase I clinical trial of CCX168, an orally-administered small molecule designed to treat autoimmune diseases.

28 Jan 2010

Novella Clinical and OSI Pharmaceuticals expand existing clinical service agreement

Novella Clinical Inc. (formerly PharmaLinkFHI) and OSI Pharmaceuticals, Inc. announced today that the Companies will expand their existing clinical service agreement. Under the terms of the new agreement, effective February 1, 2010, Novella will provide clinical research and related services to OSI for a period of two years as OSI transitions its clinical operations to its new Ardsley, New York campus. Novella will assume use of some of OSI’s facilities in Boulder and employ members of OSI’s Boulder staff.

28 Jan 2010

Most Britons not aware of the dangers of alcohol misuse

A government-funded advertising campaign launching today, backed by Cancer Research UK and other major health charities, aims to raise awareness of the unseen health damage caused by regular alcohol misuse.

28 Jan 2010

Celgene reports total revenue of $758M for fourth-quarter of 2009

Celgene Corporation announced non-GAAP (Generally Accepted Accounting Principles) net income of $290.3 million, or non-GAAP diluted earnings per share of $0.62 for the quarter ended December 31, 2009. Non-GAAP net income for the fourth quarter of 2008 was $200.9 million or non-GAAP diluted earnings per share of $0.43. Based on U.S. GAAP, Celgene reported net income of $254.2 million, or diluted earnings per share of $0.54 for the quarter ended December 31, 2009. GAAP net loss for the fourth quarter of 2008 was $149.3 million, or diluted loss per share of $0.33.

28 Jan 2010

Idera Pharmaceuticals commences IMO-3100 Phase 1 clinical trial for autoimmune diseases

Idera Pharmaceuticals, Inc. today announced initiation of a Phase 1 clinical trial of IMO-3100, an antagonist of Toll-like Receptor (TLR) 7 and TLR9.

28 Jan 2010

Patterns of urban violent injury: A spatio-temporal analysis

Each day people living in large urban centres are injured as the result of violent acts such as physical assault. While existing research tells us where such events are most likely to happen, a new study by Canadian scientists has gone one step further.

28 Jan 2010

MPM Capital leads Alnara Pharmaceuticals' $35M Series B venture capital financing

Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara’s board of directors.

28 Jan 2010

Interdisciplinary team evaluates the economic impact of mental illness in Spain

An interdisciplinary team coordinated by researchers from the University of Castilla La Mancha (UCLM) and the Canary Islands Health Service has evaluated the economic impact of mental illness in Spain, and estimated their social cost. According to the study, despite health resources being invested to alleviate the effects of such illnesses, informal care and lost work time places a heavy burden on society.

28 Jan 2010

Humans' evolutionary advantage also makes them susceptible to cancer, dementia and heart disease

The same evolutionary genetic advantages that have helped increase human lifespans also make us uniquely susceptible to diseases of aging such as cancer, heart disease and dementia, reveals a study to be published in a special PNAS collection on "Evolution in Health and Medicine" on Tuesday, Jan. 26.

28 Jan 2010

GUMC invites Washington-area residents for Spring 2010 Mini-Medical School Program

Georgetown University Medical Center (GUMC) is inviting Washington-area residents to find out what it takes to become a doctor—minus the long hours and late nights. Georgetown's eight-week Spring 2010 Mini-Medical School Program, open to the public and members of the media, begins Tuesday, March 9, 2010.

28 Jan 2010

Avonworth Middle School commended for its efforts to boost physical activity among students

During a visit today to Avonworth Middle School, Department of Health Secretary Everette James and Secretary of Education Gerald Zahorchak commended the school for its efforts to boost physical activity among students.

28 Jan 2010

Telemedicine may help community hospitals in early treatment of severely injured patients

It's known that people who live or work in rural areas are more likely to suffer and die from serious injuries compared to those in more urban environments. But while time and distance play a role in these higher mortality rates, new research suggests that limited access to early, high-quality trauma care in many smaller Ontario hospitals may be a factor.

28 Jan 2010

PIH receives medical volunteers, medical supplies to support its relief work in Haiti

Partners HealthCare in Boston and Dartmouth-Hitchcock Medical Center (DHMC) in Lebanon, NH, have sent multiple teams of medical volunteers as well as critical medical supplies and equipment to support Partners In Health's earthquake relief efforts in Haiti.

28 Jan 2010

Palliative care program may complement patients' ongoing care with symptom management and support

Georgia Sue Huston knew she was really sick. Every time the 82-year-old woman tried to turn over in her bed in the coronary care unit at Stanford Hospital & Clinics, she’d panic because she couldn’t get enough air and because it hurt so much.

28 Jan 2010

Cancer News and Research

Latest Cancer News and Research

Arthritis pain relief drug ALEVE now available OTC in British Columbia

APF survey reveals breakthrough cancer pain causes medical and financial hardships for cancer patients

OMT, a viable option for treating back pain in the third trimester of pregnancy

Genzyme implements new annual and long-term incentive plans for senior executives

iPierian receives UK patent for induced pluripotent stem cell technology

People with early-stage lung cancer may double their chances of surviving by giving up smoking

ChemoCentryx announces the initiation of Phase I clinical trial of CCX168

Novella Clinical and OSI Pharmaceuticals expand existing clinical service agreement

Most Britons not aware of the dangers of alcohol misuse

Celgene reports total revenue of $758M for fourth-quarter of 2009

Idera Pharmaceuticals commences IMO-3100 Phase 1 clinical trial for autoimmune diseases

Patterns of urban violent injury: A spatio-temporal analysis

MPM Capital leads Alnara Pharmaceuticals' $35M Series B venture capital financing

Interdisciplinary team evaluates the economic impact of mental illness in Spain

Humans' evolutionary advantage also makes them susceptible to cancer, dementia and heart disease

GUMC invites Washington-area residents for Spring 2010 Mini-Medical School Program

Avonworth Middle School commended for its efforts to boost physical activity among students

Telemedicine may help community hospitals in early treatment of severely injured patients

PIH receives medical volunteers, medical supplies to support its relief work in Haiti

Palliative care program may complement patients' ongoing care with symptom management and support

Cancer Research - Second Edition eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in